Guggenheim Partners offers $215 mn for Sun Pharma's stake

The two year old battle to take control of Israeli generic drug firm Taro Pharma has taken a new turn as the suitor Mumbai-based pharmaceutical major Sun Pharmaceuticals gets an offer to sell its holding in Taro at a premium price of $15 per share.

Related Videos